SCHEMBL6162866

SCHEMBL6162866

ClCC1CN(Cc2ccc(Cl)cc2)CCO1

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 19/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C9 P11712 1/20 0.67
DRD2 P14416 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162301 1.00 DRD4 (0.67) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6165547 1.00 DRD4 (0.67) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6165562 0.91 DRD4 (0.60) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL13840030 0.88 DRD4 (0.53) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8327024 0.86 DRD4 (0.65) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4228489 0.86 DRD4 (0.65) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6162202 0.86 DRD4 (0.67) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6226338 0.86 DRD4 (0.67) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL735729 0.86 DRD4 (0.73) DRD4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL2304936 0.86 DRD4 (0.73) DRD4CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235483-B1 CIS-JASMONE AS SEMIOCHEMICAL PLANT BIOSCIENCE LTD (GB) 2005-02-16 EP disclosed
EP-0920423-B1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH AS (DK) 2005-01-26 EP disclosed
US-20030109586-A1 Semiochemical PLANT BIOSCIENCE LIMITED (GB) 2003-06-12 US disclosed
US-6479491-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, ESPECIALLY PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2002-11-12 US disclosed
EP-1235483-A2 CIS-JASMONE AS SEMIOCHEMICAL BTG INTERNATIONAL LIMITED (GB) 2002-09-04 EP disclosed
WO-2001041568-A2 CIS-JASMONE AS SEMIOCHEMICAL BTG INTERNATIONAL LIMITED (GB) 2001-06-14 WO disclosed
US-6207662-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2001-03-27 US disclosed
EP-0760368-B1 PYRIMIDINE DERIVATIVES NISSHIN FLOUR MILLING CO (JP) 1999-07-28 EP disclosed
EP-0920423-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1999-06-09 EP disclosed
US-5736550-A TREATMENT OF GASTROINTESTINAL TRACT DISORDERS NISSHIN FLOUR MILLING CO., LTD. (JP) 1998-04-07 US disclosed
WO-1998007710-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1998-02-26 WO disclosed
EP-0760368-A1 NOVEL PYRIMIDINE DERIVATIVE NISSHIN FLOUR MILLING CO., LTD. (JP) 1997-03-05 EP disclosed